BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10211118)

  • 1. Expression of Met protein and urokinase-type plasminogen activator receptor (uPA-R) in papillary carcinoma of the thyroid.
    Zanetti A; Stoppacciaro A; Marzullo A; Ciabatta M; Fazioli F; Prat M; Comoglio PM; Baroni CD; Ruco LP
    J Pathol; 1998 Nov; 186(3):287-91. PubMed ID: 10211118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis.
    Ruco LP; Stoppacciaro A; Ballarini F; Prat M; Scarpino S
    J Pathol; 2001 May; 194(1):4-8. PubMed ID: 11329134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of a truncated form of the urokinase-type plasminogen-activator receptor in normal and tumor thyroid cells.
    Ragno P; Montuori N; Covelli B; Hoyer-Hansen G; Rossi G
    Cancer Res; 1998 Mar; 58(6):1315-9. PubMed ID: 9515821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
    Webb CP; Hose CD; Koochekpour S; Jeffers M; Oskarsson M; Sausville E; Monks A; Vande Woude GF
    Cancer Res; 2000 Jan; 60(2):342-9. PubMed ID: 10667586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Met protein in thyroid tumours.
    Ruco LP; Ranalli T; Marzullo A; Bianco P; Prat M; Comoglio PM; Baroni CD
    J Pathol; 1996 Nov; 180(3):266-70. PubMed ID: 8958803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and significance of c-met protein in papillary thyroid carcinoma.
    Inaba M; Sato H; Abe Y; Umemura S; Ito K; Sakai H
    Tokai J Exp Clin Med; 2002 Aug; 27(2):43-9. PubMed ID: 12472169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
    Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
    Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen- and colony-stimulating factor-1-associated markers in bladder carcinoma: diagnostic value of urokinase plasminogen activator receptor and plasminogen activator inhibitor type-2 using immunocytochemical analysis.
    Champelovier P; Boucard N; Levacher G; Simon A; Seigneurin D; Praloran V
    Urol Res; 2002 Oct; 30(5):301-9. PubMed ID: 12389118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activation system in active even in thyroid tumors; an immunohistochemical study.
    Ito Y; Takeda T; Kobayashi T; Wakasugi E; Tamaki Y; Umeshita K; Monden T; Shimano T; Monden M
    Anticancer Res; 1996; 16(1):81-9. PubMed ID: 8615674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Met expression in tall cell variant papillary carcinoma of the thyroid.
    Nardone HC; Ziober AF; LiVolsi VA; Mandel SJ; Baloch ZW; Weber RS; Mick R; Ziober BL
    Cancer; 2003 Oct; 98(7):1386-93. PubMed ID: 14508824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference in patterns of Met expression in papillary thyroid carcinomas and nonneoplastic thyroid tissue.
    Fluge Ø ; Haugen DR; Lillehaug JR; Varhaug JE
    World J Surg; 2001 May; 25(5):623-31. PubMed ID: 11369990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A
    Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of the components of the plasminogen activating system in human thyroid tumour derived cell lines and papillary carcinomas.
    Ulisse S; Baldini E; Toller M; Marchioni E; Giacomelli L; De Antoni E; Ferretti E; Marzullo A; Graziano FM; Trimboli P; Biordi L; Curcio F; Gulino A; Ambesi-Impiombato FS; D'Armiento M
    Eur J Cancer; 2006 Oct; 42(15):2631-8. PubMed ID: 16928445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Urokinase-type plasminogen activator (uPA), uPA receptor (uPA-R) and inhibitors (PA I -1) expression in hepatocellular carcinoma in relation to cancer invasion/metastasis and prognosis].
    Zheng Q; Tang Z; Wu Z
    Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):57-9. PubMed ID: 10921061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.
    Bhuvarahamurthy V; Schroeder J; Kristiansen G; Roigas J; Denkert C; Johannsen M; Lein M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2005 Sep; 14(3):777-82. PubMed ID: 16077991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of urokinase-type plasminogen activator and its receptor protein in synovial tissues from osteoarthritis].
    Wang WC; Wang Y; Sun CJ
    Hunan Yi Ke Da Xue Xue Bao; 2001 Jun; 26(3):257-60. PubMed ID: 12536699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator system in oral squamous cell carcinoma.
    Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
    Br J Oral Maxillofac Surg; 2007 Dec; 45(8):623-7. PubMed ID: 17590247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2 is induced by HGF stimulation in Met-positive thyroid papillary carcinoma cells and is involved in tumour invasiveness.
    Scarpino S; Duranti E; Stoppacciaro A; Pilozzi E; Natoli G; Sciacchitano S; Luciani E; Ruco L
    J Pathol; 2009 Aug; 218(4):487-94. PubMed ID: 19391129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous distribution of thyrotrophin receptor messenger ribonucleic acid (TSH-R mRNA) in papillary thyroid carcinomas detected by in situ hybridization.
    Tanaka K; Inoue H; Miki H; Komaki K; Monden Y
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):259-67. PubMed ID: 8729520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.